The global ADC Manufacturing Service market size is predicted to grow from US$ 1292 million in 2025 to US$ 1740 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.

ADC Manufacturing Service refers to a comprehensive service that specializes in providing manufacturing services related to ADCs (Antibody-Drug Conjugates). ADCs, as a new type of biological drug, combine the targeting ability of antibodies with the killing power of drugs, thus having broad application prospects in cancer treatment. ADC Manufacturing Service covers the entire production process from raw material preparation, antibody conjugation, purification, formulation to quality control. This service requires not only highly specialized skills and rigorous production processes but also a strict quality management system to ensure the safety and effectiveness of the products. Through ADC Manufacturing Service, customers can obtain high-quality ADC drugs that meet regulatory requirements, thereby accelerating their new drug development process and improving market competitiveness.

United States market for ADC Manufacturing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for ADC Manufacturing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for ADC Manufacturing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key ADC Manufacturing Service players cover Axplora, Piramal, Merck, Lonza, Creative Biolabs, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information) newest research report, the ?ADC Manufacturing Service Industry Forecast? looks at past sales and reviews total world ADC Manufacturing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected ADC Manufacturing Service sales for 2025 through 2031. With ADC Manufacturing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ADC Manufacturing Service industry.

This Insight Report provides a comprehensive analysis of the global ADC Manufacturing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ADC Manufacturing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global ADC Manufacturing Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ADC Manufacturing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ADC Manufacturing Service.

This report presents a comprehensive overview, market shares, and growth opportunities of ADC Manufacturing Service market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Clinical Services
    Commercial Services
    Others

Segmentation by Application:

    Pharmaceuticals
    Scientific Research
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Axplora
    Piramal
    Merck
    Lonza
    Creative Biolabs
    Samsung Biologics
    Carbogen-Amcis
    BOC Sciences
    GTP Bioways
    AGC Biologics
    NJ Bio
    Symbiosis-Pharma
    Aurigene Pharmaceutical Services
    Sterling
    Abzena
    WuXi XDC